Haubourdin, France

Julie Charton


 

Average Co-Inventor Count = 9.9

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Julie Charton

Introduction

Julie Charton, an accomplished inventor based in Haubourdin, France, has made significant contributions to the field of pharmaceuticals through her innovative research. With a portfolio that includes two notable patents, her work exemplifies the intersection of creativity and science.

Latest Patents

Julie’s latest patents include:

1. **Imidazol- or 1,2,4-triazol-derivatives and their use** - This innovation focuses on novel compounds represented by formula (I), including pharmaceutically acceptable salts or solvates, demonstrating potential therapeutic applications.

2. **2-oxo-3,4-dihydropyridine-5-carboxylates and their use** - Similar to her first patent, this invention also addresses novel compounds of Formula (I), with an emphasis on their pharmaceutical implications.

Career Highlights

Throughout her career, Julie has been associated with prestigious institutions, notably the University of Lille 2 Droit et Santé and Institut Pasteur de Lille. These affiliations have provided her with a robust platform to advance her research and development efforts in health and medicine.

Collaborations

Julie has collaborated with esteemed professionals such as Benoit Deprez and Florence Leroux, enhancing her projects with diverse expertise. These partnerships have been invaluable in driving forward her innovative ideas and expanding her research capabilities.

Conclusion

Julie Charton represents the spirit of innovation in the scientific community. With her patented inventions, she continues to pave the way for advancements in pharmacology and related fields, contributing to the betterment of health solutions worldwide. Her ongoing endeavors are sure to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…